Vesalio announces it has obtained its second CE mark approval spanning multiple new NeVa™ neurothrombectomy product designs and technology. The new generation NeVa devices expand on the Drop Zone™ and Smart Marker™ technologies while also introducing first-to-market features such as... - May 22, 2019
Vesalio announces it has recently raised $5 million in funding. The capital will support the continued global expansion of the NeVa™ Neurothrombectomy System, finance key clinical studies and launch new product introductions.
“We are very pleased to secure the additional capital funding,... - May 14, 2019
Vesalio announces it has executed multiple exclusive distribution agreements in Europe, Latin America, Asia and the Middle East and now has market coverage in 39 countries for the NeVa™ Neuro-thrombectomy System.
Along with the increased market and registration activities, Vesalio is expanding... - April 02, 2019
Vesalio Initiates Full Commercial Launch of NeVa at ESMINT Congress - September 12, 2018
Vesalio announces it has executed multiple exclusive distribution agreements in Europe and now has market coverage in 25 countries for the NeVa Neurothrombectomy System. All channel partners have been trained on the unique features of the NeVa platform and technique that is optimized for capturing all... - June 18, 2018
Vesalio announces it has completed European enrollment of the first twenty-five human cases in a post-market registry of the proprietary NeVa™ neurothrombectomy platform for the treatment of stroke. With procedures performed at six centers in four countries to date, early results demonstrate superior... - March 22, 2018
Vesalio announces the CE Mark certification of its first product line, the proprietary NeVa™ neurothrombectomy platform for the treatment of strokes.
Developed by a team of physicians that treat stroke, the NeVa mechanical thrombectomy technology was designed to improve “first pass”... - October 31, 2017